Epigenetic Silencing of Tumor Suppressor lncRNA <i>NKILA</i>: Implication on NF-κB Signaling in Non-Hodgkin’s Lymphoma

The long non-coding RNA (lncRNA) <i>NKILA, </i>localized to 20q13.31, is a negative regulator of NF-κB signaling implicated in carcinogenesis. As a CpG island is embedded in the promoter region of <i>NKILA</i>, it is hypothesized as a tumor suppressor lncRNA silenced by promo...

Full description

Bibliographic Details
Main Authors: Min-Yue Zhang, George Calin, Ming-Dan Deng, Rex K. H. Au-Yeung, Lu-Qian Wang, Chor-Sang Chim
Format: Article
Language:English
Published: MDPI AG 2022-01-01
Series:Genes
Subjects:
Online Access:https://www.mdpi.com/2073-4425/13/1/128
_version_ 1797493757228089344
author Min-Yue Zhang
George Calin
Ming-Dan Deng
Rex K. H. Au-Yeung
Lu-Qian Wang
Chor-Sang Chim
author_facet Min-Yue Zhang
George Calin
Ming-Dan Deng
Rex K. H. Au-Yeung
Lu-Qian Wang
Chor-Sang Chim
author_sort Min-Yue Zhang
collection DOAJ
description The long non-coding RNA (lncRNA) <i>NKILA, </i>localized to 20q13.31, is a negative regulator of NF-κB signaling implicated in carcinogenesis. As a CpG island is embedded in the promoter region of <i>NKILA</i>, it is hypothesized as a tumor suppressor lncRNA silenced by promoter DNA methylation in non-Hodgkin’s lymphoma (NHL). By pyrosequencing-verified methylation-specific PCR, <i>NKILA</i> methylation was detected in 1/10 (10%) NHL cell lines, but not in normal peripheral blood buffy coats or tonsils. <i>NKILA</i> methylation correlated with the repression of <i>NKILA</i> in cell lines. Hypomethylation treatment with 5-Aza-2′-deoxycytidine resulted in promoter demethylation and the re-expression of <i>NKILA</i>. In 102 NHL primary samples, <i>NKILA</i> was methylated in 29 (51.79%) diffuse large B-cell lymphoma (DLBCL) and 4 (20%) peripheral T-cell lymphoma cases, but unmethylated in all 26 mantle cell lymphoma cases. Mechanistically, the knockdown of <i>NKILA</i> resulted in promoting IkBα phosphorylation, associated with nucleus translocation of total p65 and phosphorylated p65 in SU-DHL-1 cells, hence constitutive NF-κB activation. Functionally, the knockdown of <i>NKILA</i> in SU-DHL-1 cells led to decreased cell death and increased cellular proliferation. Collectively, <i>NKILA</i> was a tumor suppressor lncRNA frequently hypermethylated in DLBCL. Promoter DNA methylation-mediated <i>NKILA</i> silencing resulted in increased cellular proliferation and decreased cell death via the repression of NF-κB signaling in NHL.
first_indexed 2024-03-10T01:24:34Z
format Article
id doaj.art-22d497d7fa574f698c7d5fc4f183ea53
institution Directory Open Access Journal
issn 2073-4425
language English
last_indexed 2024-03-10T01:24:34Z
publishDate 2022-01-01
publisher MDPI AG
record_format Article
series Genes
spelling doaj.art-22d497d7fa574f698c7d5fc4f183ea532023-11-23T13:52:47ZengMDPI AGGenes2073-44252022-01-0113112810.3390/genes13010128Epigenetic Silencing of Tumor Suppressor lncRNA <i>NKILA</i>: Implication on NF-κB Signaling in Non-Hodgkin’s LymphomaMin-Yue Zhang0George Calin1Ming-Dan Deng2Rex K. H. Au-Yeung3Lu-Qian Wang4Chor-Sang Chim5Department of Medicine, Queen Mary Hospital, The University of Hong Kong, Hong Kong, ChinaDepartment of Experimental Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USADepartment of Medicine, Queen Mary Hospital, The University of Hong Kong, Hong Kong, ChinaDepartment of Pathology, Queen Mary Hospital, The University of Hong Kong, Hong Kong, ChinaDepartment of Medicine, Queen Mary Hospital, The University of Hong Kong, Hong Kong, ChinaDepartment of Medicine, Queen Mary Hospital, The University of Hong Kong, Hong Kong, ChinaThe long non-coding RNA (lncRNA) <i>NKILA, </i>localized to 20q13.31, is a negative regulator of NF-κB signaling implicated in carcinogenesis. As a CpG island is embedded in the promoter region of <i>NKILA</i>, it is hypothesized as a tumor suppressor lncRNA silenced by promoter DNA methylation in non-Hodgkin’s lymphoma (NHL). By pyrosequencing-verified methylation-specific PCR, <i>NKILA</i> methylation was detected in 1/10 (10%) NHL cell lines, but not in normal peripheral blood buffy coats or tonsils. <i>NKILA</i> methylation correlated with the repression of <i>NKILA</i> in cell lines. Hypomethylation treatment with 5-Aza-2′-deoxycytidine resulted in promoter demethylation and the re-expression of <i>NKILA</i>. In 102 NHL primary samples, <i>NKILA</i> was methylated in 29 (51.79%) diffuse large B-cell lymphoma (DLBCL) and 4 (20%) peripheral T-cell lymphoma cases, but unmethylated in all 26 mantle cell lymphoma cases. Mechanistically, the knockdown of <i>NKILA</i> resulted in promoting IkBα phosphorylation, associated with nucleus translocation of total p65 and phosphorylated p65 in SU-DHL-1 cells, hence constitutive NF-κB activation. Functionally, the knockdown of <i>NKILA</i> in SU-DHL-1 cells led to decreased cell death and increased cellular proliferation. Collectively, <i>NKILA</i> was a tumor suppressor lncRNA frequently hypermethylated in DLBCL. Promoter DNA methylation-mediated <i>NKILA</i> silencing resulted in increased cellular proliferation and decreased cell death via the repression of NF-κB signaling in NHL.https://www.mdpi.com/2073-4425/13/1/128DNA methylation<i>NKILA</i>non-Hodgkin’s lymphomatumor suppressorNF-κB signaling
spellingShingle Min-Yue Zhang
George Calin
Ming-Dan Deng
Rex K. H. Au-Yeung
Lu-Qian Wang
Chor-Sang Chim
Epigenetic Silencing of Tumor Suppressor lncRNA <i>NKILA</i>: Implication on NF-κB Signaling in Non-Hodgkin’s Lymphoma
Genes
DNA methylation
<i>NKILA</i>
non-Hodgkin’s lymphoma
tumor suppressor
NF-κB signaling
title Epigenetic Silencing of Tumor Suppressor lncRNA <i>NKILA</i>: Implication on NF-κB Signaling in Non-Hodgkin’s Lymphoma
title_full Epigenetic Silencing of Tumor Suppressor lncRNA <i>NKILA</i>: Implication on NF-κB Signaling in Non-Hodgkin’s Lymphoma
title_fullStr Epigenetic Silencing of Tumor Suppressor lncRNA <i>NKILA</i>: Implication on NF-κB Signaling in Non-Hodgkin’s Lymphoma
title_full_unstemmed Epigenetic Silencing of Tumor Suppressor lncRNA <i>NKILA</i>: Implication on NF-κB Signaling in Non-Hodgkin’s Lymphoma
title_short Epigenetic Silencing of Tumor Suppressor lncRNA <i>NKILA</i>: Implication on NF-κB Signaling in Non-Hodgkin’s Lymphoma
title_sort epigenetic silencing of tumor suppressor lncrna i nkila i implication on nf κb signaling in non hodgkin s lymphoma
topic DNA methylation
<i>NKILA</i>
non-Hodgkin’s lymphoma
tumor suppressor
NF-κB signaling
url https://www.mdpi.com/2073-4425/13/1/128
work_keys_str_mv AT minyuezhang epigeneticsilencingoftumorsuppressorlncrnainkilaiimplicationonnfkbsignalinginnonhodgkinslymphoma
AT georgecalin epigeneticsilencingoftumorsuppressorlncrnainkilaiimplicationonnfkbsignalinginnonhodgkinslymphoma
AT mingdandeng epigeneticsilencingoftumorsuppressorlncrnainkilaiimplicationonnfkbsignalinginnonhodgkinslymphoma
AT rexkhauyeung epigeneticsilencingoftumorsuppressorlncrnainkilaiimplicationonnfkbsignalinginnonhodgkinslymphoma
AT luqianwang epigeneticsilencingoftumorsuppressorlncrnainkilaiimplicationonnfkbsignalinginnonhodgkinslymphoma
AT chorsangchim epigeneticsilencingoftumorsuppressorlncrnainkilaiimplicationonnfkbsignalinginnonhodgkinslymphoma